CHICAGO In a column I wrote last year, I alluded to the internationalization of biotechnology. I was wrong. This business has become global. In fact, there are now 4,284 biotech companies in 25 countries, according to a May 2004 article in BioPharm International.
The biotech industry has 622 publicly traded companies around the world.
The industry spent $......Full article >>>
tific research that begins at universities. There are still some driving forces that will allow the U.S. to maintain an edge in this industry. They are:
1. The largest pharmaceutical drug market (about 50 percent of the world market),
2. The largest conglomeration of venture capital ($2.8 billion raised for biotech in 2003, which ties for the best year in VC funding of biotech)......Full article >>>
weather the storms of going public), one sees the following trend around the world:
The governments of other countries realize the importance of this industry, and while not able to match the U.S. in funding the industry, they have been creative in stimulating the growth of their local biotech industry. Even the conservative Japanese (which have traditionally not embraced biote......Full article >>>
except its held every year). This years attendance is expected to approach 20,000 people from all over the world.
The exhibit area for this event is like walking through Epcot Center at Disney where you have all these countries and cultures represented from around the world (except that its all about biotechnology).
The Midwests presence at this event should prove much stronger......Full article >>>
Source:wistechnology.com By Michael Rosen 05/17/04Related biology technology :1
. Midwest life science stocks kept sizzling in Q22
. Midwest life science stocks sizzle in a tepid first quarter3
. A Midwest passage to India, Part II4
. Midwest offers non-stop flight to North Carolina research park5
. A Midwest life-science odyssey comes full circle6
. Midwest hotter for healthcare investments7
. A Midwest small-cap, life-science surprise package8
. 2006: A mixed blessing for Midwest life science companies9
. Midwest gaining stature in nanotech research10
. Midwest colleges strong contenders for NIH funds11
. Japan on the rebound: Implications for Midwest